TechnoMark News

The continual growth of the Digital Therapeutics market can be attributed to several factors, increasing use of smartphones and internet, increasing awareness related to digital health therapy, and rising number of chronic diseases & geriatric population. Moreover, need to curb the growing healthcare cost and provide better healthcare to population are other factors adding to the growth of the global digital therapeutics market between 2019 and 2030. To obtain better insights regarding the market scenario prominent players are increasingly focusing on collaborative initiatives with several institutes and research centers. Kaiku Health, a Helsinki-based company offering digital patient monitoring and patient-reported outcome services, collaborated with Turku University Hospital & Amgen (Finland) to launch a digital symptom tracking for multiple myeloma, a type of bone marrow cancer. This digital health therapy would support and guide patients in their treatment regime. Major Key...

Digital therapeutics market was valued at $2,238 million in 2018 and is expected to reach $9,640 million by 2026 with a CAGR of 19.9% during the forecast period. Digital therapeutics provides evidence-based therapeutic interventions to patients. It is driven by software programs and devices to prevent, manage, or treat a medical condition. Digital therapeutics software application can be used independently or in combination with devices, medications, or any other therapies to provide patient care and health outcomes. These products incorporate advanced technology, best practices regarding the design, usability, clinical validation, and data security. These products are reviewed and approved by regulatory bodies before use. Furthermore, digital therapeutics empower patients, healthcare providers, and payers with intelligent and accessible tools for addressing a wide range of conditions through high quality, safe, and effective data-driven interventions. Major Key Players of the Digital ...

  Digital therapeutics market is anticipated to witness a double digit CAGR from 2019 to 2030 and was valued at over US$ 140.0 Mn in 2018. It is anticipated to grow at a CAGR of 26.8% from 2019 to 2030. The continual growth of the Digital Therapeutics market can be attributed to several factors, increasing use of smartphones and internet, increasing awareness related to digital health therapy, and rising number of chronic diseases & geriatric population. Moreover, need to curb the growing healthcare cost and provide better healthcare to population are other factors adding to the growth of the global digital therapeutics market between 2019 and 2030. To obtain better insights regarding the market scenario prominent players are increasingly focusing on collaborative initiatives with several institutes and research centers. Kaiku Health, a Helsinki-based company offering digital patient monitoring and patient-reported outcome services, collaborated with Turku University Hospital ...

The population of geriatric population across the world has grown rapidly over the past several decades. Moreover, this growth has witnessed an unprecedented rate in recent times. In 2016, it was approximated that the population of individuals aged 65 years or older was 8.5% or 617 million of the entire world population. Furthermore, it is projected that the figure will witness an increment to 17% i.e. 1.6 billion by the end of 2050. Such rapid growth of geriatric population is anticipated to present a remunerative growth opportunity for the global digital therapeutics market in the coming times. As geriatric population requires constant healthcare and services & software on mobile or remote monitoring enable better care and this has been a major growth driver for the global digital therapeutic industry. Treatment of several conditions namely blood glucose monitoring, diabetes, cardiovascular diseases have gained immense popularity in recent times, which is further anticipated grow...

Digital therapeutics market is anticipated to witness a double digit CAGR from 2019 to 2030 and was valued at over US$ 140.0 Mn in 2018. It is anticipated to grow at a CAGR of 26.8% from 2019 to 2030. The continual growth of the Digital Therapeutics market can be attributed to several factors, increasing use of smartphones and internet, increasing awareness related to digital health therapy, and rising number of chronic diseases & geriatric population. Moreover, need to curb the growing healthcare cost and provide better healthcare to population are other factors adding to the growth of the global digital therapeutics market between 2019 and 2030. To obtain better insights regarding the market scenario prominent players are increasingly focusing on collaborative initiatives with several institutes and research centers. Kaiku Health, a Helsinki-based company offering digital patient monitoring and patient-reported outcome services, collaborated with Turku University Hospital & A...

  Digital therapeutics market is anticipated to witness a double digit CAGR from 2019 to 2030 and was valued at over US$ 140.0 Mn in 2018. It is anticipated to grow at a CAGR of 26.8% from 2019 to 2030. The continual growth of the Digital Therapeutics market can be attributed to several factors, increasing use of smartphones and internet, increasing awareness related to digital health therapy, and rising number of chronic diseases & geriatric population. Moreover, need to curb the growing healthcare cost and provide better healthcare to population are other factors adding to the growth of the global digital therapeutics market between 2019 and 2030. To obtain better insights regarding the market scenario prominent players are increasingly focusing on collaborative initiatives with several institutes and research centers. Kaiku Health, a Helsinki-based company offering digital patient monitoring and patient-reported outcome services, collaborated with Turku University Hospital ...

Digital therapeutic products are today incorporated with improved technology and optimal practices for designing, usability, clinical validation, and data security. They are reviewed several times and approved by the associated regulatory bodies as needed in terms of reducing risk, improving efficacy, and no compromise on the intended use. The current pandemic situation of Coronavirus in almost all the economies across the globe is forcing healthcare sector to innovate and adopted modernized technologies to treat the speedily rising positive cases and soon stabilize the panic among public. Owing to the rising focus on social distancing and quarantine on most regions, the demand for digital therapeutics is anticipated to grow speedily for the treatment of chronic illnesses. Major Key Players of the Digital Therapeutics Market are: Pear Therapeutics, Proteus Digital Health, 2Morrow, Omada Health, Livongo Health, Ginger.Io, Noom, Mango Health, Canary Health, and Propeller Health among...

Digital therapeutics provides evidence-based therapeutic interventions to patients. It is driven by software programs and devices to prevent, manage, or treat a medical condition. Digital therapeutics software application can be used independently or in combination with devices, medications, or any other therapies to provide patient care and health outcomes. These products incorporate advanced technology, best practices regarding the design, usability, clinical validation, and data security. These products are reviewed and approved by regulatory bodies before use. Furthermore, digital therapeutics empower patients, healthcare providers, and payers with intelligent and accessible tools for addressing a wide range of conditions through high quality, safe, and effective data-driven interventions. Increase in adoption of smartphones and tablets coupled with healthcare apps, growth in need to control healthcare cost, and rise in incidence of chronic diseases drive the growth of the global ...

Digital therapeutics market is anticipated to witness a double digit CAGR from 2019 to 2030 and was valued at over US$ 140.0 Mn in 2018. It is anticipated to grow at a CAGR of 26.8% from 2019 to 2030. Digital Therapeutics is a form of digitalized health solution which utilizes the likes of online and digital health technologies, to treat several psychological and medical conditions. These applications assist patients and medical professionals to track various health related data and provide options for remote monitoring, thereby, providing means to improve long-term health conditions. The global digital therapeutic market is driven by can be attributed to several factors, increasing use of smartphones and internet, increasing awareness related to digital health therapy, and rising number of chronic diseases & geriatric population. Moreover, need to curb the growing healthcare cost and provide better healthcare to population. However, lack of awareness and data security of customer...